Markets
markets

Gold tops $5,000 per ounce for the first time

Gold stormed past the $5,000-per-oz threshold for the first time ever, extending a historic rally fueled by growing geopolitical tensions, central bank buying, and a weaker dollar.

After first crossing the milestone in trading on Sunday, bullion pushed even higher in early action on Monday, topping $5,110. The latest extension of the shiny metal’s blinding rally has been boosted by the continued sell-off of the US dollar. Indeed, the US Dollar Index has now hit its lowest mark since 2021, following weekend speculation over a joint US-Japan intervention on the yen after the New York Federal Reserve reportedly conducted rate checks — where officials ask dealers what price they would get were they to enter the market — on Friday. The US dollar has shed ~3.2% against the Japanese currency since Thursday.

The surge in precious metals continues to be buoyed by enhanced retail attention, with the iShares Silver Trust and SPDR Gold Shares ETF far and away the most referenced tickers on the r/WallStreetBets subreddit over the past 12 hours.

Gold Silver Top Trending 1/26/26
Source: SwaggyStocks

Geopolitical tensions between the US and NATO over Greenland, increased American pressure against Iran, and the Trump administration seizing Venezuelan President Nicolás Maduro have also helped pushed the price of gold in recent months, contributing to a blockbuster 68% rally in the past year. Other precious metals like silver, which has become a favorite among retail traders in its own right, also surged to a record $110 per ounce on Monday.

Last week, Goldman Sachs hiked its year-end gold price forecast to $5,400 per ounce, as analysts at the investment bank expect continued rampant central bank buying, as well as increased retail attention and ETF inflows, to drive further demand.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.